Who
Javier San Martin
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, LeonaBio; Chief Medical Officer, Arrowhead Pharmaceuticals.
In numbers
- Trades disclosed
- 39
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $4.2M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 19 Nov 2020
- Last trade
- 9 Apr 2026
- Last filed
- 13 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Apr 2026filed 13 Apr 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 9 Apr 2026filed 13 Apr 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 4 Mar 2026filed 5 Mar 2026 | LONA LeonaBioBiotechnology | SEC FORM 4 Sold | $9,2361,720 at $5.37 | filing |
| 4 Mar 2026filed 5 Mar 2026 | LONA LeonaBioBiotechnology | SEC FORM 4 Sold | $9,2361,720 at $5.37 | filing |
| 3 Mar 2026filed 5 Mar 2026 | LONA LeonaBioBiotechnology | SEC FORM 4 Code M | —7,418 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —7,418 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —7,418 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | LONA LeonaBioBiotechnology | SEC FORM 4 Code M | —7,418 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | Athira PharmaBiotechnology | SEC FORM 4 Sold | $11K1,644 at $6.88 | filing |
| 2 Jan 2026filed 5 Jan 2026 | LONA LeonaBioBiotechnology | SEC FORM 4 Sold | $11K1,644 at $6.88 | filing |
| 31 Dec 2025filed 5 Jan 2026 | Athira PharmaBiotechnology | SEC FORM 4 Code M | —4,667 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | Athira Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,667 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —4,667 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | LONA LeonaBioBiotechnology | SEC FORM 4 Code M | —4,667 at $0.00 | filing |
| 24 Dec 2025filed 29 Dec 2025 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —44,508 at $0.00 | filing |
| 1 Jul 2025filed 2 Jul 2025 | LONA LeonaBioBiotechnology | SEC FORM 4 Sold | $3,14410,842 at $0.29 | filing |
| 30 Jun 2025filed 2 Jul 2025 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code M | —46,666 at $0.00 | filing |
| 30 Jun 2025filed 2 Jul 2025 | LONA LeonaBioBiotechnology | SEC FORM 4 Code M | —46,666 at $0.00 | filing |
| 3 Mar 2025filed 4 Mar 2025 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —111,270 at $0.00 | filing |
| 3 Mar 2025filed 4 Mar 2025 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —74,180 at $0.00 | filing |
News
Athira Pharma (NASDAQ:LONA) Upgraded at Wall Street ZenLONA · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name Javier San Martin; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.